Clinical trials and diagnostic advances

The World Health Organization (WHO) has launched clinical trials for two experimental treatments and granted emergency-use authorization for the first molecular diagnostic test specifically designed to detect the latest strain of the virus. It also recently began the first clinical trial of the ChAdOx1 Ebola vaccine, led by the University of Oxford.

Continued efficacy concerns and warnings

The WHO warned that the virus continues to evolve, underscoring the need for sustained efforts to contain its spread.